On June 1, 2022, Cytek Biosciences, Inc. held its 2022 annual meeting of stockholders, elected Deborah Neff, Don Hardison as Class I director.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.69 USD | +4.98% | -1.22% | -37.61% |
05-29 | Sector Update: Health Care Stocks Lean Lower Premarket Wednesday | MT |
05-29 | Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.61% | 711M | |
+8.22% | 217B | |
+15.81% | 195B | |
+31.20% | 112B | |
+3.76% | 65.83B | |
+14.73% | 52.67B | |
+4.70% | 49.86B | |
-3.79% | 38.18B | |
-0.53% | 35.39B | |
+23.72% | 31.02B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Elects Deborah Neff, Don Hardison as Class I Director